Eli Lilly attributes the resolution of the shortage to intensified efforts in production and distribution ... remain on the FDA’s shortage list. Novo Nordisk recently indicated that the shortage ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

Market OverviewThe global Healthcare Distribution Market is valued at USD 1048.4 Billion in 2024 and is projected to reach a ...